|
|||||
|
|
Phase II study of pazopanib in combination with paclitaxel in patients with metastatic melanoma |
|
| Authors: | Fruehauf John P. El-Masry Monica Osann Katherine Parmakhtiar Basmina Yamamoto Maki Jakowatz James G. |
| Affiliation: | 1.Division of Hematology/Oncology, Chao Family Comprehensive Cancer Center, University of California, 101 The City Drive South, Bldg 56, Orange, Irvine, CA, 92868, USA ;2.Division of Surgical Oncology, Chao Family Comprehensive Cancer Center, University of California, 101 The City Drive South, Bldg 56, Orange, Irvine, CA, 92868, USA ; |
| Abstract: | Cancer Chemotherapy and Pharmacology - This phase II study evaluated the safety and clinical activity of pazopanib, a potent and mutlitargeted tyrosine kinase inhibitor (TKI) of vascular... |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |